Lanqun Qin

321 Zhongshan Road
Nanjing, 210008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

The application of continuous enteral nutrition during sequential chemoradiotherapy and immunotherapy in patients with esophageal cancer: a retrospective study.

The application of continuous enteral nutrition during sequential chemoradiotherapy and immunotherapy in patients with esophageal cancer: a retrospective study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: March 11, 2026

Faecal microbiota transplantation combined with platinum-based doublet chemotherapy and tislelizumab as first-line treatment for driver-gene negative advanced non-small cell lung cancer (NSCLC): study protocol for a prospective, multicentre, single-arm exploratory trial.

Faecal microbiota transplantation combined with platinum-based doublet chemotherapy and tislelizumab as first-line treatment for driver-gene negative advanced non-small cell lung cancer (NSCLC): study protocol for a prospective, multicentre, single-arm exploratory trial.

Journal: BMJ open

Published: March 04, 2025

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade.

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade.

Journal: Cancer immunology, immunotherapy : CII

Published: January 19, 2025

Fecal microbiota transplantation enhanced the effect of chemoimmunotherapy by restoring intestinal microbiota in LLC tumor-bearing mice.

Fecal microbiota transplantation enhanced the effect of chemoimmunotherapy by restoring intestinal microbiota in LLC tumor-bearing mice.

Journal: BMC immunology

Published: October 12, 2024

Chronological Effects of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.

Chronological Effects of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.

Journal: Immunology

Published: August 02, 2024

β-glucan combined with Envafolimab and Endostar as immune rechallenge for metastatic non-small cell lung cancer.

β-glucan combined with Envafolimab and Endostar as immune rechallenge for metastatic non-small cell lung cancer.

Journal: BMC immunology

Published: July 20, 2024

Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma.

Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma.

Journal: Cancer immunology, immunotherapy : CII

Published: February 16, 2024

Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapy.

Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapy.

Journal: Journal of translational medicine

Published: July 02, 2023

Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.

Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.

Journal: Journal of translational medicine

Published: November 04, 2022

Rapid Response to the Combination of Lenvatinib and Sintilimab in a Pancreatic Acinar Cell Carcinoma Patient With Elevated Alpha-Fetoprotein: A Case Report.

Rapid Response to the Combination of Lenvatinib and Sintilimab in a Pancreatic Acinar Cell Carcinoma Patient With Elevated Alpha-Fetoprotein: A Case Report.

Journal: Frontiers in oncology

Published: April 08, 2021

Distinct genomic traits of acral and mucosal melanomas revealed by targeted mutational profiling.

Distinct genomic traits of acral and mucosal melanomas revealed by targeted mutational profiling.

Journal: Pigment cell & melanoma research

Published: August 23, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026